CRIS Current Research Information System

COLECCHIA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.950
AS - Asia 6.076
EU - Europa 5.052
AF - Africa 401
SA - Sud America 297
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.787
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.891
VN - Vietnam 1.820
SG - Singapore 1.578
CN - Cina 1.500
GB - Regno Unito 1.441
IT - Italia 704
DE - Germania 636
SE - Svezia 588
FR - Francia 369
HK - Hong Kong 361
IN - India 325
RU - Federazione Russa 285
UA - Ucraina 259
IE - Irlanda 195
BR - Brasile 192
ZA - Sudafrica 133
NL - Olanda 121
EE - Estonia 115
JP - Giappone 111
CI - Costa d'Avorio 102
CH - Svizzera 101
TG - Togo 65
FI - Finlandia 59
JO - Giordania 57
KR - Corea 47
PH - Filippine 45
AR - Argentina 41
NG - Nigeria 39
BD - Bangladesh 37
CA - Canada 37
TH - Thailandia 36
BG - Bulgaria 34
SC - Seychelles 34
BE - Belgio 25
PL - Polonia 25
EC - Ecuador 24
TR - Turchia 24
TW - Taiwan 24
GR - Grecia 23
ES - Italia 21
IR - Iran 16
MX - Messico 16
ID - Indonesia 15
LB - Libano 13
PK - Pakistan 13
IQ - Iraq 12
LT - Lituania 10
SA - Arabia Saudita 10
CL - Cile 8
CO - Colombia 8
HR - Croazia 8
UZ - Uzbekistan 8
PE - Perù 7
AU - Australia 6
KE - Kenya 6
AT - Austria 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
IL - Israele 5
PY - Paraguay 5
VE - Venezuela 5
BO - Bolivia 4
EG - Egitto 4
AL - Albania 3
AO - Angola 3
DK - Danimarca 3
MD - Moldavia 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
EU - Europa 2
HN - Honduras 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MM - Myanmar 2
MT - Malta 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MK - Macedonia 1
NO - Norvegia 1
Totale 19.782
Salva come PNG Salva come JPEG
Città #
Southend 1.308
Singapore 1.055
Fairfield 941
Ashburn 803
Chandler 606
Woodbridge 397
Houston 371
Seattle 369
Wilmington 368
Santa Clara 343
Ho Chi Minh City 335
Hong Kong 332
Dong Ket 317
San Jose 298
Hanoi 292
Cambridge 290
Ann Arbor 276
Princeton 266
Beijing 209
Dublin 194
Boardman 164
Jacksonville 152
Nanjing 137
Bologna 130
Lauterbourg 128
Westminster 127
Padova 119
Hefei 111
Abidjan 102
Los Angeles 100
Tokyo 98
Bern 86
New York 83
Frankfurt am Main 74
Berlin 66
Lomé 65
Saint Petersburg 62
Da Nang 59
Buffalo 58
Dallas 58
Amman 57
Medford 57
San Diego 57
Shenyang 57
Milan 53
Haiphong 52
Dearborn 51
Jinan 48
Helsinki 47
Abeokuta 39
Changsha 37
Hebei 37
Shanghai 36
Seoul 34
Guangzhou 33
Nanchang 33
Sofia 33
Tianjin 33
Turin 32
Bremen 30
Munich 29
Redondo Beach 29
Jiaxing 27
Mülheim 25
Florence 23
São Paulo 23
Brussels 22
Redwood City 22
Biên Hòa 21
Falkenstein 21
Hangzhou 21
Orem 21
Mahé 20
Yubileyny 20
Hải Dương 19
Des Moines 18
Norwalk 18
Kuban 17
Ningbo 17
Toronto 17
Falls Church 16
Mountain View 16
Xi'an 16
London 15
Phoenix 15
Pune 15
Wuhan 15
Bangkok 14
Can Tho 14
Brooklyn 13
Chicago 13
Haikou 13
Rome 13
Shenzhen 13
Zhengzhou 13
Fuzhou 12
Taizhou 12
Guayaquil 11
Kunming 11
Lanzhou 11
Totale 12.906
Salva come PNG Salva come JPEG
Nome #
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 303
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 301
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 283
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 275
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 245
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 239
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 235
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 227
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 218
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 216
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 215
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 213
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 213
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 213
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 212
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 209
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 208
Benign hepatic nodular lesions after treatment for childhood cancer 202
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 198
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 197
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 197
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 197
H 2breath testing for other gas-related syndromes 193
Gut Microbiota and Celiac Disease 188
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 188
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 187
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 187
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 186
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 180
null 179
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 178
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 176
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 172
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 172
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 172
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 171
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 171
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 170
Pharmacological modulation of MRP2 in primary biliary cirrhosis 169
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 167
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 164
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 163
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 162
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 162
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 162
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 162
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 162
Persistent Fever and Abdominal Pain in a Young Woman With Budd-Chiari Syndrome 161
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 160
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 160
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 160
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 160
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 158
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 158
Biliary symptoms, gallbladder motility, and cholecystectomy 157
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 156
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 155
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 154
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 151
Gut microbiota and metabolic syndrome. 150
Calcolosi della colecisti complicata 149
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. 149
Gut microbiota and its pathophysiology in disease paradigms. 149
Safety of interferon beta treatment for chronic HCV hepatitis. 148
Breath tests with stable isotopes: have they a role in liver transplantation? 148
Prognostic factors for hepatocellular carcinoma recurrence 148
Management of hepatic encephalopathy: focus on antibiotic therapy 148
MALDI-TOF MS protein profiling using selective extraction with derivatized cellulose and chemometric analysis: from hepatitis C to hepatocellular carcinoma 146
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 145
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 144
Serum TUDCA/UDCA concentration profiles after TUDCA oral load: A new test for intestinal transit time and bacteria overgrowth evaluation 143
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. 143
Primary biliary cholangitis-primary sclerosing cholangitis in an evolving overlap syndrome: A case report 142
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 142
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 142
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. 141
Coeliac disease and autoimmune hepatitis: Gluten-free diet can influence liver disease outcome. 141
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 141
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 141
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation variant. Result of an open, uncontrolled , multicenter trial. 139
Hepatic steatosis in obese patients: clinical aspects and prognostic significance. 139
Bacteria flora,gas and antibiotics 139
The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report 139
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 139
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 138
Salivary TUDCA concentration profiles after TUDCA oral load: a non-invasive test for intestinal transit time evaluation 137
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, costipation-variant: results of a multicenter trial 134
Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma:back to the future 132
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study 131
Italian consensus conference for colonic diverticulosis and diverticular disease 131
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 131
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure 131
Ecosistema intestinale: aspetti fisiopatologici e terapeutici 130
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 125
Risk factors for gallstone formation during weight loss 125
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 124
Development and application of a simple and powerful tool for nutrition and lifestyle education for the Italian general population by general practitioners and family paediatricians 124
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 124
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 124
Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancy. 123
Totale 16.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.887
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021810 0 0 0 0 0 0 0 0 0 81 83 646
2021/20222.583 241 119 139 156 211 143 60 119 88 149 771 387
2022/20232.529 286 355 158 324 162 195 52 134 454 61 176 172
2023/2024640 38 114 38 72 43 150 23 51 35 31 22 23
2024/20252.451 94 450 223 158 481 127 144 56 33 184 59 442
2025/20265.105 362 414 475 389 599 333 697 123 1.333 380 0 0
Totale 20.121